SRI

An FDA-Approved Drug, Ondansetron, Significantly Decreased OCD Severity in Clinical Trial Participants Also Taking SRI Medications
Results of a new clinical trial shed light on mechanisms that may give rise to some of the repetitive behaviors experienced in obsessive-compulsive disorder (OCD) and Tourette’s disorder. The results… Read More
Some OCD Patients Who Attain “Wellness” After Exposure Therapy May Safely Taper Off Their SRI Medicines, Study Suggests
The first-line treatment for adult obsessive-compulsive disorder (OCD) is typically a prescription for an SRI (serotonin reuptake inhibitor) drug, medications most often used to treat depression.… Read More